Autonomix Medical (AMIX) Cash & Equivalents (2022 - 2026)

Autonomix Medical (AMIX) has reported Cash & Equivalents for 4 consecutive years, with $9.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash & Equivalents fell 16.1% year-over-year to $9.9 million; the TTM figure through Dec 2025 stood at $9.9 million (down 16.1% YoY), while the FY2025 annual figure was $9.1 million, up 6.13% from the prior year.
• Cash & Equivalents rose to $9.9 million in Q4 2025 per AMIX's latest filing, from $7.5 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $11.8 million in Q4 2024 and bottomed at $810000.0 in Q4 2022.
• Historically, Cash & Equivalents has averaged $6.4 million across 4 years, with a median of $7.5 million in 2025.
• Annual changes were most pronounced in 2024 — Cash & Equivalents surged 895.14% — and 2025, when it decreased 16.1%.
• Autonomix Medical's Cash & Equivalents stood at $810000.0 in 2022, then jumped by 50.37% to $1.2 million in 2023, then jumped by 868.8% to $11.8 million in 2024, then declined by 16.1% to $9.9 million in 2025.
• Business Quant data shows AMIX's Cash & Equivalents at $9.9 million in Q4 2025, $7.5 million in Q3 2025, and $8.6 million in Q2 2025.